Literature DB >> 26055697

Pfizer steps up battle to defend control of pregabalin.

Andrew Jack.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26055697     DOI： 10.1136/bmj.h3119

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care.

Authors:  Richard Croker; Darren Smyth; Alex J Walker; Ben Goldacre
Journal:  BMJ Open       Date:  2018-06-07       Impact factor: 2.692

2.  Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database.

Authors:  Leticia Ortiz de Landaluce; Pere Carbonell; Carmen Asensio; Núria Escoda; Pilar López; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.